Xilio Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2024 | 4.57 M | $3.60 M | 20.64% | 7.20% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 3.00 M | $2.37 M | 0.00% | 4.73% |
| MORGAN STANLEY | 11/14/2024 | 1.52 M | $1.20 M | 36.79% | 2.40% |
| RIVERVEST VENTURE MANAGEMENT LLC | 10/30/2024 | 1.44 M | $1.14 M | 0.00% | 2.27% |
| FMR LLC | 11/13/2024 | 1.40 M | $1.10 M | 0.00% | 2.20% |
| VANGUARD GROUP INC | 11/13/2024 | 902,531 | $711,195 | 0.00% | 1.42% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 338,192 | $266,420 | 84.95% | 0.53% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 272,486 | $214,637 | 0.00% | 0.43% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 266,300 | $209,765 | -9.73% | 0.42% |
| FIL LTD | 11/13/2024 | 218,705 | $172,274 | 0.00% | 0.34% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 75,624 | $59,569 | 100.00% | 0.12% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 71,081 | $55,991 | 0.00% | 0.11% |
| TWO SIGMA SECURITIES, LLC | 11/14/2024 | 44,445 | $35,009 | 234.90% | 0.07% |
| STATE STREET CORP | 11/14/2024 | 43,390 | $34,178 | 0.00% | 0.07% |
| SEVENBRIDGE FINANCIAL GROUP, LLC | 11/12/2024 | 41,000 | $44,690 | 0.00% | 0.06% |
| RAYMOND JAMES & ASSOCIATES | 10/18/2024 | 38,825 | $30,582 | 0.00% | 0.06% |
| ENGINEERS GATE MANAGER LP | 11/14/2024 | 32,752 | $25,799 | 100.00% | 0.05% |
| MARINER, LLC | 11/13/2024 | 25,317 | $19,942 | 100.00% | 0.04% |
| XTX TOPCO LTD | 11/14/2024 | 23,862 | $18,796 | -28.32% | 0.04% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 20,655 | $16,270 | 69.23% | 0.03% |
| AVANTAX PLANNING PARTNERS, INC. | 11/14/2024 | 20,483 | $16,134 | -18.07% | 0.03% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/14/2024 | 20,000 | $15,754 | 100.00% | 0.03% |
| UBS GROUP AG | 11/14/2024 | 15,733 | $12,397 | 7,727.36% | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 10,389 | $8,183 | 100.00% | 0.02% |
| DUNHILL FINANCIAL, LLC | 11/15/2024 | 10,274 | $8,093 | 0.00% | 0.02% |
| PINNACLE FINANCIAL GROUP, LLC / IL | 11/12/2024 | 10,000 | $7,877 | 0.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 5,616 | $4,425 | 33.49% | 0.01% |
| KEY FINANCIAL INC | 10/29/2024 | 830 | $654 | 0.00% | 0.00% |
| PRIVATE WEALTH MANAGEMENT GROUP, LLC | 10/29/2024 | 310 | $245 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 266 | $209 | -61.56% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 75 | $59 | 27.12% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Xilio Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 38 institutional investors and hedge funds held shares of Xilio Therapeutics, Inc.. The most heavily invested institutionals were:
Bain Capital Life Sciences Investors, LLC: 4.57 M
Rock Springs Capital Management LP: 3 M
MORGAN STANLEY: 1.52 M
RiverVest Venture Management LLC: 1.44 M
FMR LLC: 1.4 M
VANGUARD GROUP INC: 902,531
22.81% of Xilio Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 15.42 M shares in the last 24 months. This purchase volume represents approximately $14.96 M in transactions.